Your browser doesn't support javascript.
loading
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model.
Thirukkumaran, Chandini M; Shi, Zhong Qiao; Nuovo, Gerard J; Luider, Joanne; Kopciuk, Karen A; Dong, Yuan; Mostafa, Ahmed A; Thakur, Satbir; Gratton, Kathy; Yang, Ailian; Chin, Alex C; Coffey, Matt C; Jimenez-Zepeda, Victor H; Stewart, Douglas; Chesi, Marta; Bergsagel, P Leif; Morris, Don.
Afiliação
  • Thirukkumaran CM; Translational Research Laboratories, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Shi ZQ; Translational Research Laboratories, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Nuovo GJ; Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus, OH.
  • Luider J; Phylogeny Inc., Powell, OH.
  • Kopciuk KA; Flow Cytometry Laboratory, Department of Pathology and Laboratory Medicine, Alberta Public Laboratories, Calgary, AB, Canada.
  • Dong Y; Cancer Control, Department of Cancer Epidemiology and Prevention Research, Alberta Health Services.
  • Mostafa AA; Department of Mathematics and Statistics.
  • Thakur S; Department of Oncology, and.
  • Gratton K; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
  • Yang A; Department of Mathematics and Statistics.
  • Chin AC; Histocompatibility and Immunogenetics Laboratory, Department of Pathology and Laboratory Medicine, Alberta Public Laboratories, Calgary, AB, Canada.
  • Coffey MC; Translational Research Laboratories, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Jimenez-Zepeda VH; Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Stewart D; Translational Research Laboratories, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Chesi M; Clinical Section of Clinical Biochemistry, Alberta Public Laboratories, Calgary, AB, Canada.
  • Bergsagel PL; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Morris D; Oncolytics Biotech, Calgary, AB, Canada.
Blood Adv ; 3(5): 797-812, 2019 03 12.
Article em En | MEDLINE | ID: mdl-30850386
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Terapia Combinada / Terapia Viral Oncolítica / Bortezomib / Imunoterapia / Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Terapia Combinada / Terapia Viral Oncolítica / Bortezomib / Imunoterapia / Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá